| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18,722 |
1,868 |
$809K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20,569 |
2,142 |
$574K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,403 |
873 |
$295K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,133 |
602 |
$271K |
| 99000 |
|
5,381 |
835 |
$100K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,141 |
602 |
$85K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
854 |
256 |
$9K |